Table 5 Theoretical framework of criteria which can be used to decide whether monitoring for specific AEs is useful.
No. needed to screen? (1/prevalence per year) | Severity? (Low/moderate/high) | Cost of screening? (Low/moderate/high) | Feasibility of scoring? (Low/moderate/high) | |
---|---|---|---|---|
Body weight | 1.5 6 | Low | Low | High |
Blood pressure | ? | Moderate | Low | High |
Peripheral oedema | ? | Low | Low | High |
Heart failure | ? | High | Moderate | Moderate* |
Dyslipidemia | ? | Moderate | Moderate | Moderate* |
Blood/urine glucose | 12.5 6 | Moderate | Moderate | High |
Glaucoma | 18.1 84 | Moderate | Moderate | Moderate* |
*Scoring in daily practice depends on presence of accurate laboratory tests and/or eye‐pressure measurement equipment.